Zai Lab Limited
ZLAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $399 | $267 | $215 | $144 |
| % Growth | 49.6% | 24% | 49% | – |
| Cost of Goods Sold | $148 | $96 | $74 | $52 |
| Gross Profit | $251 | $171 | $141 | $92 |
| % Margin | 62.9% | 64.1% | 65.6% | 63.8% |
| R&D Expenses | $235 | $266 | $286 | $573 |
| G&A Expenses | $299 | $282 | $197 | $219 |
| SG&A Expenses | $299 | $282 | $259 | $219 |
| Sales & Mktg Exp. | $0 | $0 | $62 | $0 |
| Other Operating Expenses | $0 | -$10 | $0 | $0 |
| Operating Expenses | $533 | $537 | $545 | $792 |
| Operating Income | -$282 | -$367 | -$404 | -$700 |
| % Margin | -70.7% | -137.4% | -188% | -485.1% |
| Other Income/Exp. Net | $25 | $32 | -$39 | -$3 |
| Pre-Tax Income | -$257 | -$335 | -$443 | -$703 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$257 | -$335 | -$443 | -$704 |
| % Margin | -64.4% | -125.5% | -206.1% | -488.2% |
| EPS | -2.6 | -34.6 | -46.3 | -75.8 |
| % Growth | 92.5% | 25.3% | 38.9% | – |
| EPS Diluted | -2.6 | -34.6 | -46.3 | -75.8 |
| Weighted Avg Shares Out | 99 | 10 | 10 | 9 |
| Weighted Avg Shares Out Dil | 99 | 10 | 10 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $37 | $40 | $15 | $2 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $20 | $9 | $8 | $6 |
| EBITDA | -$235 | -$365 | -$435 | -$689 |
| % Margin | -58.8% | -136.9% | -202.2% | -477.8% |